相关实验视频

Updated: Jan 8, 2026

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

在肺结核患者的血中进行Feedforward基于控制的捆绑管理

XiangYa Li¹, Jing Yuan¹, YaQin Tang¹

¹Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan Province, 415000, People's Republic of China.

Journal of multidisciplinary healthcare

|December 24, 2025

概括

食前控制捆绑管理显著降低了肺结核患者的血复发和严重程度. 这种护理干预改善了患者的结果,减少了焦虑,增加了满意度.

科学领域:

护理干预护理干预
肺结核管理肺结核管理
血液溶解控制血液溶解控制

背景情况:

肺结核 (TB) 患者经常经历血,这是一个严重的并发症.
标准的护理干预措施可能无法完全解决结核病中血管理的复杂性.
反控制为管理复杂的患者护理途径提供了一种积极的方法.

研究的目的:

评估基于前控制的捆绑管理系统的构建和应用.
评估该系统在肺结核患者的血液溶解方面的护理干预措施中的有效性.
将标准护理和新干预措施之间的临床结果和患者评估进行比较.

主要方法:

对112名住院肺结核患者的回顾性研究.
干预组 (n=59) 接受了前期控制捆绑管理;对照组 (n=53) 接受了标准护理.
测量结果:停止血的时间,住院,复发,大规模血,手术率,并发症,服从性,焦虑 (HAMA) 和满意度 (PSQ-18).

主要成果:

干预组表现出明显更短的时间来停止血 (P <0.001).
干预组中血复发,大规模血复发和支气管动脉栓塞率较低 (P <0.05).
在干预组 (P <0.001) 中改善了患者的服从和满意度,并减少了焦虑 (HAMA分数).

结论:

前进控制捆绑管理有效地预防了肺结核的血复发和严重程度.
这一策略缩短了血的持续时间,减少了窒息相关的发病率和死亡率,并提高了患者的福祉.
这种方法显著改善了患者的服从,满意度和焦虑水平.

关键词:

窒息症 (asphyxia) 是一种窒息症.捆绑管理捆绑管理料前期控制料前期控制血栓溶解 (hemoptysis) 是一种血液溶解.护理护理护理结核病是一种肺结核病.

更多相关视频

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: